145 related articles for article (PubMed ID: 25105941)
1. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK
Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941
[TBL] [Abstract][Full Text] [Related]
2. The Ubiquitin Sensor and Adaptor Protein p62 Mediates Signal Transduction of a Viral Oncogenic Pathway.
Wang L; Howell MEA; Sparks-Wallace A; Zhao J; Hensley CR; Nicksic CA; Horne SR; Mohr KB; Moorman JP; Yao ZQ; Ning S
mBio; 2021 Oct; 12(5):e0109721. PubMed ID: 34488443
[TBL] [Abstract][Full Text] [Related]
3. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.
Liu H; Zheng H; Duan Z; Hu D; Li M; Liu S; Li Z; Deng X; Wang Z; Tang M; Shi Y; Yi W; Cao Y
Mol Cancer; 2009 Oct; 8():92. PubMed ID: 19860880
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.
Luftig M; Prinarakis E; Yasui T; Tsichritzis T; Cahir-McFarland E; Inoue J; Nakano H; Mak TW; Yeh WC; Li X; Akira S; Suzuki N; Suzuki S; Mosialos G; Kieff E
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15595-600. PubMed ID: 14673102
[TBL] [Abstract][Full Text] [Related]
5. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
Cahir-McFarland ED; Carter K; Rosenwald A; Giltnane JM; Henrickson SE; Staudt LM; Kieff E
J Virol; 2004 Apr; 78(8):4108-19. PubMed ID: 15047827
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus LMP1 manipulates the content and functions of extracellular vesicles to enhance metastatic potential of recipient cells.
Nkosi D; Sun L; Duke LC; Meckes DG
PLoS Pathog; 2020 Dec; 16(12):e1009023. PubMed ID: 33382850
[TBL] [Abstract][Full Text] [Related]
7. Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.
Hatton O; Lambert SL; Krams SM; Martinez OM
PLoS One; 2012; 7(8):e42610. PubMed ID: 22880054
[TBL] [Abstract][Full Text] [Related]
8. Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos.
Vaysberg M; Hatton O; Lambert SL; Snow AL; Wong B; Krams SM; Martinez OM
J Biol Chem; 2008 Dec; 283(52):36573-85. PubMed ID: 18986987
[TBL] [Abstract][Full Text] [Related]
9. Fascin is a key regulator of breast cancer invasion that acts via the modification of metastasis-associated molecules.
Al-Alwan M; Olabi S; Ghebeh H; Barhoush E; Tulbah A; Al-Tweigeri T; Ajarim D; Adra C
PLoS One; 2011; 6(11):e27339. PubMed ID: 22076152
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors.
Ma Y; Walsh MJ; Bernhardt K; Ashbaugh CW; Trudeau SJ; Ashbaugh IY; Jiang S; Jiang C; Zhao B; Root DE; Doench JG; Gewurz BE
Cell Host Microbe; 2017 May; 21(5):580-591.e7. PubMed ID: 28494239
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr Virus LMP1-Mediated Oncogenicity.
Wang LW; Jiang S; Gewurz BE
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835489
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes.
Tomita M; Dewan MZ; Yamamoto N; Kikuchi A; Mori N
Cancer Sci; 2009 May; 100(5):807-12. PubMed ID: 19309363
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the Role of Epstein-Barr Virus Latent Membrane Protein 1 in Immune Modulation: A Multifaced Signalling Perspective.
Šimičić P; Batović M; Stojanović Marković A; Židovec-Lepej S
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675906
[TBL] [Abstract][Full Text] [Related]
14. Expression of the epidermodysplasia verruciformis-associated genes EVER1 and EVER2 is activated by exogenous DNA and inhibited by LMP1 oncoprotein from Epstein-Barr virus.
Frecha C; Chevalier SA; van Uden P; Rubio I; Siouda M; Saidj D; Cohen C; Lomonte P; Accardi R; Tommasino M
J Virol; 2015 Jan; 89(2):1461-7. PubMed ID: 25378492
[TBL] [Abstract][Full Text] [Related]
15. Characterization of target gene regulation by the two Epstein-Barr virus oncogene LMP1 domains essential for B-cell transformation.
Mitra B; Beri NR; Guo R; Burton EM; Murray-Nerger LA; Gewurz BE
mBio; 2023 Nov; 14(6):e0233823. PubMed ID: 38009935
[TBL] [Abstract][Full Text] [Related]
16. Monastrol suppresses invasion and metastasis in human colorectal cancer cells by targeting fascin independent of kinesin-Eg5 pathway.
Alburquerque-González B; Montoro-García S; Bernabé-García Á; Bernabé-García M; Campioni-Rodrigues P; Rodríguez-Martínez A; Luque I; Salo T; Pérez-Garrido A; Pérez-Sánchez H; Cayuela ML; Luengo-Gil G; Luchinat E; Postigo-Corrales F; Staderini T; Nicolás FJ; Conesa-Zamora P
Biomed Pharmacother; 2024 Jun; 175():116785. PubMed ID: 38781869
[TBL] [Abstract][Full Text] [Related]
17. A nanobody inhibitor of Fascin-1 actin-bundling activity and filopodia formation.
Burgess SG; Paul NR; Richards MW; Ault JR; Askenatzis L; Claydon SG; Corbyn R; Machesky LM; Bayliss R
Open Biol; 2024 Mar; 14(3):230376. PubMed ID: 38503329
[TBL] [Abstract][Full Text] [Related]
18. The Actin Crosslinker Fascin Regulates Cell Chirality.
Zhang H; Fan J; Maclin JMA; Wan LQ
Adv Biol (Weinh); 2023 Jun; 7(6):e2200240. PubMed ID: 36658789
[TBL] [Abstract][Full Text] [Related]
19. NF-κB as a target for oncogenic viruses.
Sun SC; Cesarman E
Curr Top Microbiol Immunol; 2011; 349():197-244. PubMed ID: 20845110
[TBL] [Abstract][Full Text] [Related]
20. Lanthanide-Based Peptide-Directed Visible/Near-Infrared Imaging and Inhibition of LMP1.
Chau HF; Wu Y; Fok WY; Thor W; Cho WC; Ma P; Lin J; Mak NK; Bünzli JG; Jiang L; Long NJ; Lung HL; Wong KL
JACS Au; 2021 Jul; 1(7):1034-1043. PubMed ID: 34467347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
